ArticleFrontiers in immunology2019
Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.
0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 71 citations in OpenAlex.
- Protection of mice against septic shock induced by lethal intraperitoneal dose of LPS by a recombinantMicrobiology spectrum · 2026Article
- Regulating the regulators via targeting CD38 in the tumor microenvironment.Frontiers in immunology · 2026Review
- Exploring the causal relationship between immune factors and chondrosarcoma: a Mendelian randomization study.Discover oncology · 2025Article
- Mass cytometric analysis of circulating immune landscape in primary central nervous system lymphoma.Frontiers in immunology · 2025Article
- Macrophage Transcriptomic Alterations Driven by Alphavirus-Based Cancer Immunotherapy Vectors.Journal of immunology research · 2025Article
- Changes in the Phenotype and Metabolism of Peritoneal Macrophages in Mucin-2 Knockout Mice and Partial Restoration of Their Functions In Vitro After L-Fucose Treatment.International journal of molecular sciences · 2024Article
- Tissue-Resident Macrophages in Cancer: Friend or Foe?Cancer medicine · 2024Review
- Augmenting fibronectin levels in injured adult CNS promotes axon regeneration in vivo.Experimental neurology · 2024Article
- Encapsulated Mesenchymal Stromal Cells as Cyclic Providers of Immunomodulatory Secretomes: A Living on-Demand Delivery System.Advanced healthcare materials · 2024Article
- Unveiling the Potential of Extracellular Vesicles as Biomarkers and Therapeutic Nanotools for Gastrointestinal Diseases.Pharmaceutics · 2024Review
- Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection.BMC cancer · 2024Article
- OMIP-095: 40-Color spectral flow cytometry delineates all major leukocyte populations in murine lymphoid tissues.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2023Article
- Advantages and disadvantages of treatment of experimental ARDS by M2-polarized RAW 264.7 macrophages.Heliyon · 2023Article
- A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization.Scientific reports · 2023Article
- The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy.Science immunology · 2023Review
- Evolving roles of CD38 metabolism in solid tumour microenvironment.British journal of cancer · 2023Review
- CD38 marks the exhausted CD8Frontiers in immunology · 2023Article
- TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content.Frontiers in immunology · 2023Article
- A multiplex inhalation platform to modelFrontiers in pharmacology · 2023Article
- Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial.Journal of experimental & clinical cancer research : CR · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 6 institutions in 2 countries.
Jian Hang LamDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Harry Ho Man NgDuke-NUS Medical School, Singapore, Singapore.
Chun Jye LimTranslational Immunology Institute (TII), SingHealth DukeNUS Academic Medical Centre, Singapore, Singapore.
Xin Ni SimDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Fabio MalavasiDepartment of Medical Science, University of Turin and Fondazione Ricerca Molinette, Turin, Italy.
Huihua LiDivision of Medicine, Singapore General Hospital, Singapore, Singapore.
Josh Jie Hua LohDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Khin SabaiDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Joo-Kyung KimDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Clara Chong Hui OngDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Tracy LohDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Wei Qiang LeowDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Su Pin ChooDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Han Chong TohDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Ser Yee LeeDuke-NUS Medical School, Singapore, Singapore.
Chung Yip ChanDepartment of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore, Singapore.
Valerie ChewTranslational Immunology Institute (TII), SingHealth DukeNUS Academic Medical Centre, Singapore, Singapore.
Tong Seng LimA. Menarini Biomarkers Singapore Pte Ltd., Singapore, Singapore.
Joe YeongDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Tony Kiat Hon LimDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Singapore General Hospital · SGDuke-NUS Medical School · SGNational Cancer Centre Singapore · SGSingHealth Duke-NUS Academic Medical Centre · SGFondazione Ricerca Molinette · ITTemasek Polytechnic · SG
Funding
Biomaterials Directed Cell Polarity and MigrationR01GM112017 · NIGMS · UNIVERSITY OF CINCINNATI · PI HO, CHIA-CHI · 2014 to 2016
$992kNIGMS NIH HHS R01 GM112017
Abstract
PubMed holds no abstract for this paper.
Indexed as
ADP-ribosyl Cyclase 1Carcinoma, HepatocellularCytokinesHumansLiverLiver NeoplasmsLymphocytes, Tumor-InfiltratingMacrophagesMembrane GlycoproteinsMiddle AgedPrognosisTHP-1 CellsADP-ribosyl Cyclase 1CD38 protein, humanCytokinesMembrane GlycoproteinscancerCD38hepatocellular carcinomamacrophagemarkerprognosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.